"Regeneron Pharmaceuticals has reported a temporary interruption of bulk manufacturing production at its Raheen facility in Co Limerick due to unanticipated facility repairs."
"The production pause at the Limerick facility has had a notable impact on the entire group's margin, as indicated in the latest quarterly results."
Regeneron Pharmaceuticals has announced a temporary halt in bulk manufacturing production at its facility in Limerick, attributed to unanticipated facility repairs. This interruption has affected the entire group's profit margins. The details regarding this production pause were disclosed in the company's latest quarterly results, indicating the significance of the issue on overall operations and financial performance.
Read at Independent
Unable to calculate read time
Collection
[
|
...
]